Anlon Healthcare Ltd.'s initial public offering (IPO) has concluded with robust investor interest, marking a significant milestone for the company. The mainboard IPO witnessed an impressive 7.12 times oversubscription, reflecting strong market enthusiasm.

Subscription Details

The IPO received applications for over 9.47 crore shares against the 1.33 crore shares on offer, indicating substantial demand across various investor categories:

• Retail Investors: Led the charge with a staggering 47.29 times oversubscription
• Non-Institutional Investors: Showed strong interest with 10.61 times subscription
• Qualified Institutional Buyers (QIBs): The category was fully subscribed

IPO Pricing and Grey Market Premium

Note: Potential listing price is based on the upper price band and current grey market premium

Key Dates for Investors

Note: Listing is anticipated on both BSE and NSE

How to Check Allotment Status

Investors can verify their application status through:

1. National Stock Exchange (NSE) website
2. Bombay Stock Exchange (BSE) website
3. Kfin Technologies website (the registrar for this IPO)

The strong oversubscription across all investor categories, particularly the retail segment, suggests a positive sentiment towards Anlon Healthcare's market debut. However, investors should note that market conditions and company performance post-listing can influence the stock's performance beyond the initial enthusiasm seen in the IPO phase.

As the healthcare sector continues to draw attention, Anlon Healthcare's public debut will be closely watched by market participants. The company's performance in the coming days will provide further insights into investor confidence and the broader market appetite for new listings in the healthcare space.

Anlon Healthcare's Initial Public Offering (IPO) concluded its subscription period today, marking the end of a significant milestone for the pharmaceutical intermediates manufacturer. The mainboard issue garnered substantial interest from investors across various categories.

Subscription Details

The IPO witnessed an overall subscription of 3.67 times, with investors bidding for 4,39,34,124 shares against the 1,33,00,000 shares on offer. Here's a breakdown of the subscription rates across different investor categories:

IPO Specifics

• Issue Size: Rs 121.03 crore
• Fresh Issue: 1.33 crore shares
• Price Band: Rs 86 - Rs 91 per share

Grey Market Premium

The grey market is showing a premium of Rs 5 for Anlon Healthcare shares. This suggests a potential listing price of Rs 96, compared to the upper price band of Rs 91, indicating expected gains of 5.49% for investors.

Key Dates

• Share Allotment: September 1
• Listing Date: September 3 (on BSE and NSE)

Company Profile

Anlon Healthcare, founded in 2013, specializes in the manufacture of high-purity pharmaceutical intermediates and active pharmaceutical ingredients. Their product portfolio caters to various sectors including:

• Medicines
• Nutraceuticals
• Personal care products
• Animal health products

The strong subscription numbers, particularly in the retail segment, suggest significant investor interest in Anlon Healthcare's business model and growth prospects. However, it's important to note that grey market premiums and subscription rates are not guaranteed indicators of future stock performance.

Investors and market watchers will be keenly observing the share allotment process on September 1 and the subsequent listing on September 3 on both the Bombay Stock Exchange (BSE) and National Stock Exchange (NSE).